Literature DB >> 21698707

Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization.

Andrew B Rosenkrantz1, Lorenzo Mannelli, Xiangtian Kong, Ben E Niver, Douglas S Berkman, James S Babb, Jonathan Melamed, Samir S Taneja.   

Abstract

PURPOSE: To retrospectively assess the utility of fusion of T2-weighted images (T2WI) and high b-value diffusion-weighted images (DWI) for prostate cancer detection and localization.
MATERIALS AND METHODS: In this IRB-approved HIPAA-compliant study, 42 patients with prostate cancer underwent MRI including multiplanar T2WI and axial DWI before prostatectomy. Two independent radiologists first assessed multiplanar T2WI and axial DWI(b-1000) images and recorded whether tumor was present in each sextant. Axial T2WI was then fused with axial DWI(b-1000) images, and the radiologists re-evaluated each sextant for tumor. Accuracy was compared using generalized estimating equations based on a binary logistic regression model.
RESULTS: The accuracy, sensitivity, specificity, PPV, and NPV for tumor detection on a sextant-basis using separate and fused image sets was 65.1%, 50.8%, 78.0%, 67.8%, and 63.6% and 71.0%, 60.8%, 80.3%, 73.7%, and 69.3%, respectively, for reader 1, and 54.0%, 42.5%, 64.4%, 52.0%, and 55.2%, and 61.1%, 56.7%, 65.2%, 59.6%, and 62.3%, respectively, for reader 2. The improvements in accuracy, sensitivity, and NPV using fused images were statistically significant for both readers, as was the improvement in PPV for reader 2 (P ranging from <0.0001 to 0.041). With either separate or fused images, there was greater sensitivity for tumors of higher grade or larger size (P ranging from <0.001 to 0.099).
CONCLUSION: Fusion of T2WI and high b-value DWI resulted in significant improvements in sensitivity and accuracy for tumor detection on a sextant-basis, with similar specificity.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21698707     DOI: 10.1002/jmri.22598

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  19 in total

1.  Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI.

Authors:  C Orczyk; H Rusinek; A B Rosenkrantz; A Mikheev; F-M Deng; J Melamed; S S Taneja
Journal:  Clin Radiol       Date:  2013-08-28       Impact factor: 2.350

2.  [Value of PI-RADS v2 scores combined with prostate specific antigen in diagnosis of peripheral zone prostate cancer: a logistic regression analysis].

Authors:  Li-Zhi Lei; Yi-Kai Xu; Mei-Rong Hou; Meng-Qi He
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

3.  Comparison of T2(*) mapping with diffusion-weighted imaging in the characterization of low-grade vs intermediate-grade and high-grade prostate cancer.

Authors:  Lian-Ming Wu; Zi-Zhou Zhao; Xiao-Xi Chen; Qing Lu; Shi-Teng Suo; Qiang Liu; Jiani Hu; E Mark Haccke; Jian-Rong Xu
Journal:  Br J Radiol       Date:  2016-04-19       Impact factor: 3.039

4.  Diffusion-weighted MR imaging in gynecologic cancers.

Authors:  Shigenobu Motoshima; Hiroyuki Irie; Takahiko Nakazono; Toshiharu Kamura; Sho Kudo
Journal:  J Gynecol Oncol       Date:  2011-12-05       Impact factor: 4.401

5.  Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.

Authors:  Kyung Won Doo; Deuk Jae Sung; Beom Jin Park; Min Ju Kim; Sung Bum Cho; Yu Whan Oh; Young Hwii Ko; Kyung Sook Yang
Journal:  Eur Radiol       Date:  2012-04-01       Impact factor: 5.315

6.  Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate.

Authors:  Meredith Sadinski; Milica Medved; Ibrahim Karademir; Shiyang Wang; Yahui Peng; Yulei Jiang; Steffen Sammet; Gregory Karczmar; Aytekin Oto
Journal:  Abdom Imaging       Date:  2015-10

7.  Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.

Authors:  Matthew D Greer; Joanna H Shih; Nathan Lay; Tristan Barrett; Leonardo Kayat Bittencourt; Samuel Borofsky; Ismail M Kabakus; Yan Mee Law; Jamie Marko; Haytham Shebel; Francesca V Mertan; Maria J Merino; Bradford J Wood; Peter A Pinto; Ronald M Summers; Peter L Choyke; Baris Turkbey
Journal:  Radiology       Date:  2017-07-19       Impact factor: 11.105

Review 8.  Prostate specific antigen: the past, present and future.

Authors:  Harcharan Gill; Jonathan Wu
Journal:  Curr Urol       Date:  2013-02-08

9.  A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk.

Authors:  E J Bass; A Pantovic; M Connor; R Gabe; A R Padhani; A Rockall; H Sokhi; H Tam; M Winkler; H U Ahmed
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-11-20       Impact factor: 5.554

10.  Low-to-high b value DWI ratio approaches in multiparametric MRI of the prostate: feasibility, optimal combination of b values, and comparison with ADC maps for the visual presentation of prostate cancer.

Authors:  Yin Xi; Alexander Liu; Franklin Olumba; Parker Lawson; Daniel N Costa; Qing Yuan; Gaurav Khatri; Takeshi Yokoo; Ivan Pedrosa; Robert E Lenkinski
Journal:  Quant Imaging Med Surg       Date:  2018-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.